Projetos selecionados 2021

Exibir informações Ocultar informações

Code

Area

Project

Center

Project leader

Budget (€)

CC21-10026

Therapeutics

First-in-class small drug inhibitor of Hakai against carcinoma metastasis

Fundación Profesor Novoa Santos

Angélica Figueroa Conde-Valvís

300.000

CC21-10070

Therapeutics

AON Therapeutics

Centre de Regulació Genòmica

Jordi Hernández Ribera

300.000

CC21-10016

Medical Devices

BraiN20, the new standard of care to improve the management of Acute Ischemic Stroke (AIS) patients

Institut d’Investigació en Ciencies de la Salut Germans Trias i Pujol

Alicia Martínez Piñeiro, MD

300.000

Projetos selecionados 2020

Exibir informações Ocultar informações

Code

Area

Project

Center

Project leader

Budget (€)

CF92-00003

Med tech

Endovascular patches for aortic diseases

Institut Químic de Sarrià (IQS)

Jordi Martorell

300.000

CF92-00009

Med tech

Phenotyping Circulating Tumor Cells to monitor cancer dynamics

LABORATORIO IBERICO INTERNACIONAL DE NANOTECNOLOGIA

Lorena Diéguez

299.420

CF92-00010

Med tech

ABLE REGAIN - Robotic Exoskeleton for Gait trAining with Intensive Neurorehabilitation after stroke

Universitat Politècnica de Catalunya (UPC)

Alfons Carnicero

300.000

Projetos selecionados 2019

Exibir informações Ocultar informações

Code

Area

Project

Center

Project leader

Budget (€)

CF91-00005

Therapeutics

A breakthrough alternative to antibiotics for curing bacterial infectious diseases at Intensive Care

Fundació d'Investigació Biomèdica de Bellvitge (IDIBELL)

Rafael Mañez Mendiluce

300.000

CF91-00008

Med tech

RAD51PREDICT: a companion diagnostic (CDx) test to enable personalized medicine in cancer

Fund.priv.institut Investigació Oncologica Vall Hebron (VHIO)

Alba Llop Guevara

300.000

CF91-00002

Therapeutics

A first-in-class AAV-gene therapy for the curative treatment of Friedreich’s Ataxia

Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP)

Antoni Matilla Dueñas

300.000

CF91-00010

Therapeutics

Precise gene editing technologies for advanced therapies

Universitat Pompeu Fabra (UPF)

Marc Güell

300.000

 

Projetos selecionados 2021

<@liferay.language key='wos-mostrar-info' /> <@liferay.language key='wos-ocultar-info' />

Code

Area

Project

Center

Project leader

Budget (€)

CC21-10026

Therapeutics

First-in-class small drug inhibitor of Hakai against carcinoma metastasis

Fundación Profesor Novoa Santos

Angélica Figueroa Conde-Valvís

300.000

CC21-10070

Therapeutics

AON Therapeutics

Centre de Regulació Genòmica

Jordi Hernández Ribera

300.000

CC21-10016

Medical Devices

BraiN20, the new standard of care to improve the management of Acute Ischemic Stroke (AIS) patients

Institut d’Investigació en Ciencies de la Salut Germans Trias i Pujol

Alicia Martínez Piñeiro, MD

300.000

Projetos selecionados 2020

<@liferay.language key='wos-mostrar-info' /> <@liferay.language key='wos-ocultar-info' />

Code

Area

Project

Center

Project leader

Budget (€)

CF92-00003

Med tech

Endovascular patches for aortic diseases

Institut Químic de Sarrià (IQS)

Jordi Martorell

300.000

CF92-00009

Med tech

Phenotyping Circulating Tumor Cells to monitor cancer dynamics

LABORATORIO IBERICO INTERNACIONAL DE NANOTECNOLOGIA

Lorena Diéguez

299.420

CF92-00010

Med tech

ABLE REGAIN - Robotic Exoskeleton for Gait trAining with Intensive Neurorehabilitation after stroke

Universitat Politècnica de Catalunya (UPC)

Alfons Carnicero

300.000

Projetos selecionados 2019

<@liferay.language key='wos-mostrar-info' /> <@liferay.language key='wos-ocultar-info' />

Code

Area

Project

Center

Project leader

Budget (€)

CF91-00005

Therapeutics

A breakthrough alternative to antibiotics for curing bacterial infectious diseases at Intensive Care

Fundació d'Investigació Biomèdica de Bellvitge (IDIBELL)

Rafael Mañez Mendiluce

300.000

CF91-00008

Med tech

RAD51PREDICT: a companion diagnostic (CDx) test to enable personalized medicine in cancer

Fund.priv.institut Investigació Oncologica Vall Hebron (VHIO)

Alba Llop Guevara

300.000

CF91-00002

Therapeutics

A first-in-class AAV-gene therapy for the curative treatment of Friedreich’s Ataxia

Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP)

Antoni Matilla Dueñas

300.000

CF91-00010

Therapeutics

Precise gene editing technologies for advanced therapies

Universitat Pompeu Fabra (UPF)

Marc Güell

300.000